When.com Web Search

  1. Ads

    related to: buy asthma inhaler asda pharmacy

Search results

  1. Results From The WOW.Com Content Network
  2. Some drugmakers to cap cost of asthma inhalers at $35 a month

    www.aol.com/news/drugmakers-cap-cost-asthma...

    Starting Saturday, the cost of inhalers will fall for many Americans, as new out-of-pocket price caps go into effect for the asthma medications from AstraZeneca and Boehringer Ingelheim.

  3. Anti-asthmatic agent - Wikipedia

    en.wikipedia.org/wiki/Anti-asthmatic_agent

    An anti-asthmatic agent, also known as an anti-asthma drug, refers to a drug that can aid in airway smooth muscle dilation to allow normal breathing during an asthma attack or reduce inflammation on the airway to decrease airway resistance for asthmatic patients, or both.

  4. Inhaler - Wikipedia

    en.wikipedia.org/wiki/Inhaler

    An inhaler (puffer, asthma pump or allergy spray) is a medical device used for delivering medicines into the lungs through the work of a person's breathing. This allows medicines to be delivered to and absorbed in the lungs, which provides the ability for targeted medical treatment to this specific region of the body, as well as a reduction in the side effects of oral medications.

  5. What is an asthma spacer device and how do you use it? - AOL

    www.aol.com/news/asthma-spacer-device-000000940.html

    An asthma inhaler works most effectively if you deliver your medication slowly, so this is where a spacer device can be useful to help you achieve this goal. Many people using metered dose ...

  6. Budesonide/formoterol - Wikipedia

    en.wikipedia.org/wiki/Budesonide/formoterol

    Budesonide/formoterol, sold under the brand name Symbicort among others, is a fixed-dose combination medication used in the management of asthma or chronic obstructive pulmonary disease (COPD). [2]

  7. Fluticasone furoate/vilanterol - Wikipedia

    en.wikipedia.org/wiki/Fluticasone_furoate/vilanterol

    The combination was approved by the FDA for use as a long-term, once-daily, maintenance treatment in people with COPD in 2013. The FDA label was changed in April 2015, to add an indication for a once-daily treatment of asthma in people aged 18 years of age and older. [3]